Published in Adv Exp Med Biol on January 01, 1994
Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev (2008) 1.64
The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol (2006) 1.41
Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem (2009) 1.21
Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol (2004) 1.14
Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem Pharmacol (2008) 1.13
Ring-cleaving dioxygenases with a cupin fold. Appl Environ Microbiol (2012) 1.06
Bidens pilosa L. (Asteraceae): Botanical Properties, Traditional Uses, Phytochemistry, and Pharmacology. Evid Based Complement Alternat Med (2013) 1.05
Architectural phenotypes in the transparent testa mutants of Arabidopsis thaliana. J Exp Bot (2009) 1.03
Dietary flavonoids and flavonoid-rich foods are not associated with risk of type 2 diabetes in postmenopausal women. J Nutr (2006) 1.03
Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir Res (2010) 1.02
Differential hepatoprotective mechanisms of rutin and quercetin in CCl(4)-intoxicated BALB/cN mice. Acta Pharmacol Sin (2012) 1.01
Quercetin-induced ubiquitination and down-regulation of Her-2/neu. J Cell Biochem (2008) 0.96
Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis. Invest New Drugs (2008) 0.92
Effects of olive oil and its fractions on oxidative stress and the liver's fatty acid composition in 2,4-Dichlorophenoxyacetic acid-treated rats. Nutr Metab (Lond) (2010) 0.87
Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model. PLoS One (2014) 0.85
The potential role of honey and its polyphenols in preventing heart diseases: a review. Afr J Tradit Complement Altern Med (2010) 0.85
Quercetin Inhibits α3β4 Nicotinic Acetylcholine Receptor-Mediated Ion Currents Expressed in Xenopus Oocytes. Korean J Physiol Pharmacol (2011) 0.84
Antioxidant effects of the ethanol extract from flower of Camellia japonica via scavenging of reactive oxygen species and induction of antioxidant enzymes. Int J Mol Sci (2011) 0.83
Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. Int J Nanomedicine (2013) 0.82
Structural basis of the anti-inflammatory activity of quercetin: inhibition of the 5-hydroxytryptamine type 2 receptor. Eur Biophys J (2009) 0.81
The Protective Effect of Quercetin-3-O-β-D-Glucuronopyranoside on Ethanol-induced Damage in Cultured Feline Esophageal Epithelial Cells. Korean J Physiol Pharmacol (2011) 0.81
Protective effects of plant seed extracts against amyloid β-induced neurotoxicity in cultured hippocampal neurons. J Pharm Bioallied Sci (2013) 0.81
Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab (Lond) (2015) 0.80
Protective effect of Artemisia annua L. extract against galactose-induced oxidative stress in mice. PLoS One (2014) 0.79
Advances in the analytical methods for determining the antioxidant properties of honey: a review. Afr J Tradit Complement Altern Med (2011) 0.79
Flavonol and flavone intake and the risk of intermittent claudication in male smokers. Eur J Epidemiol (2004) 0.78
Dietary olive oil effect on antioxidant status and fatty acid profile in the erythrocyte of 2,4-D- exposed rats. Lipids Health Dis (2010) 0.78
Rutin exerts antiulcer effect by inhibiting the gastric proton pump. Indian J Pharmacol (2013) 0.78
Alleviation of podophyllotoxin toxicity using coexisting flavonoids from Dysosma versipellis. PLoS One (2013) 0.77
Chemical composition and antioxidant activities of essential oils from different parts of the oregano. J Zhejiang Univ Sci B (2017) 0.75
Tea (Camellia sinensis) infusions ameliorate cancer in 4TI metastatic breast cancer model. BMC Complement Altern Med (2017) 0.75
Differential Effects of Quercetin and Quercetin Glycosides on Human α7 Nicotinic Acetylcholine Receptor-Mediated Ion Currents. Biomol Ther (Seoul) (2016) 0.75
Flavonoid intake and the risk of age-related cataract in China's Heilongjiang Province. Food Nutr Res (2015) 0.75
Antioxidant activity of polyphenolic myricetin in vitro cell- free and cell-based systems. Mol Biol Res Commun (2016) 0.75
Comparative Study of Novel Ratio Spectra and Isoabsorptive Point Based Spectrophotometric Methods: Application on a Binary Mixture of Ascorbic Acid and Rutin. J Anal Methods Chem (2016) 0.75
Effects of Payena dasyphylla (Miq.) on hyaluronidase enzyme activity and metalloproteinases protein expressions in interleukin-1β stimulated human chondrocytes cells. BMC Complement Altern Med (2013) 0.75
Physical properties and biological activities of hesperetin and naringenin in complex with methylated β-cyclodextrin. Beilstein J Org Chem (2015) 0.75
Cashew apple extract inhibition of fat storage and insulin resistance in the diet-induced obesity mouse model. J Nutr Sci (2015) 0.75
Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells. World J Gastroenterol (2016) 0.75
Antioxidant and cytoprotective activities of Piper betle, Areca catechu, Uncaria gambir and betel quid with and without calcium hydroxide. BMC Complement Altern Med (2013) 0.75
Evaluation of Cassia tora Linn. against Oxidative Stress-induced DNA and Cell Membrane Damage. J Pharm Bioallied Sci (2017) 0.75
Cervical screening and health inequality in England in the 1990s. J Epidemiol Community Health (2003) 2.67
Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1972) 1.71
Vancomycin anaphylaxis and successful desensitization. Ann Allergy (1994) 1.64
Autonomic imbalance in asthma with special reference to beta adrenergic blockade. Adv Intern Med (1972) 1.56
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
The anatomical and biochemical basis of bronchial obstruction in asthma. Ann Intern Med (1965) 1.42
Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther (1989) 1.32
Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium. J Pharm Sci (1980) 1.28
Metabolic response to epinephrine in bronchial asthma. J Allergy (1968) 1.26
Allergy-related diseases and cancer: an inverse association. Am J Epidemiol (1985) 1.25
Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans. J Pharm Sci (1982) 1.18
IgE levels in sera of children with asthma. Pediatrics (1971) 1.15
Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol (1989) 1.15
Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions. J Epidemiol Community Health (2008) 1.15
A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis (1989) 1.14
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (1993) 1.10
Ascorbic acid-enhanced antiproliferative effect of flavonoids on squamous cell carcinoma in vitro. Anticancer Drugs (1993) 1.10
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr (1982) 1.08
Effect of hydrocortisone on immunoglobulin synthesis and secretion by human peripheral lymphocytes in vitro. Int Arch Allergy Appl Immunol (1972) 1.06
Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol (1999) 1.03
Quercetin: an inhibitor of antigen-induced human basophil histamine release. J Immunol (1981) 1.03
Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J Pharmacokinet Biopharm (1994) 1.02
Role of calcium and calcium antagonists in airway function. Eur J Respir Dis Suppl (1983) 1.02
Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol (1984) 0.98
Effects of flavonoids and transitional metal cations on antigen-induced histamine release from human basophils. Biochem Pharmacol (1982) 0.96
Effect of carbohydrates on estimated hepatic blood flow. Clin Pharmacol Ther (1984) 0.95
Discordant allergic manifestations in monozygotic twins: genetic identity versus clinical, physiologic, and biochemical differences. J Allergy (1971) 0.95
Effects of smooth muscle calcium antagonists on human basophil histamine release. Biochem Pharmacol (1981) 0.94
Effect of adrenergic compounds, aminophylline and hydrocortisone, on in vitro immunoglobulin synthesis by normal human peripheral lymphocytes. J Allergy Clin Immunol (1973) 0.94
The effect of phentolamine on adenylate cyclase and on isoproterenol stimulation in leukocytes from asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1973) 0.93
Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone. Clin Pharmacol Ther (1991) 0.92
Fatal varicella in a corticosteroid-dependent asthmatic receiving troleandomycin. Allergy Proc (1990) 0.92
Regulatory role of prostaglandin E in allergic histamine release with observations on the responsiveness of basophil leukocytes and the effect of acetylsalicylic acid. J Allergy Clin Immunol (1977) 0.92
Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther (1992) 0.90
Airway smooth muscle in exercise-induced bronchospasm: some speculations. Pediatrics (1975) 0.90
Newer drugs in management. Calcium antagonists. Chest (1985) 0.90
Disodium cromoglycate in bronchial asthma. Ann Intern Med (1969) 0.90
Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man. J Pharmacokinet Biopharm (1992) 0.90
Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. Anticancer Drugs (1992) 0.89
A dose-response study of the bronchodilator action of azelastine in asthma. J Allergy Clin Immunol (1987) 0.87
Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (1996) 0.87
Naturally occurring flavonoids and human basophil histamine release. Int Arch Allergy Appl Immunol (1985) 0.86
Calcium antagonists and asthma. J Allergy Clin Immunol (1985) 0.86
Release of histamine from rat mast cells by lysosomal cationic proteins. Possible involvement of adenylate cyclase and adenosine triphosphatase in pharmacologic regulation. Int Arch Allergy Appl Immunol (1973) 0.85
Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett (1991) 0.85
Inhibition of reverse transcriptases by flavonoids. Antiviral Res (1989) 0.85
Flavonoid modulation of human neutrophil function. J Allergy Clin Immunol (1984) 0.85
The effects of a beta-2 selective adrenergic agonist and a beta-nonselective antagonist on theophylline clearance. J Clin Pharmacol (1987) 0.84
Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism. Life Sci (1982) 0.84
The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am J Surg (1989) 0.84
Prednisolone disposition in steroid-dependent asthmatic children. J Allergy Clin Immunol (1981) 0.84
Asthma deaths: are they preventable? N Engl Reg Allergy Proc (1988) 0.83
Reductions in cardiovascular risk in association with population screening: a 10-year longitudinal study. J Public Health (Oxf) (2007) 0.82
Increased adenosine triphosphatase in leukocytes of asthmatic children. J Clin Invest (1974) 0.81
Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. J Allergy Clin Immunol (1990) 0.81
Tumor promoter-induced basophil histamine release: effect of selected flavonoids. Biochem Pharmacol (1987) 0.80
Lymphocyte blast transformation. II. The mechanism of action of alpha adrenergic receptor effects. Int Arch Allergy Appl Immunol (1971) 0.80
Drug-induced changes of adenylate cyclase activity in cells from asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1977) 0.80
Lack of effect of atenolol on the pharmacokinetics of theophylline. Br J Clin Pharmacol (1988) 0.79
Inhibition by quercetin of thyroid hormone stimulation in vitro of human red blood cell Ca2+-ATPase activity. Cell Calcium (1983) 0.79
Clinical conference: Severe obstructive lung disease in a 14-year-old girl with alpha-1 antitrypsin deficiency. J Allergy Clin Immunol (1976) 0.79
Collaborative asthma self-management. Evaluation designs. Clin Rev Allergy (1987) 0.79
The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. J Allergy Clin Immunol (1986) 0.78
Comparison of the effects of quercetin with those of other flavonoids on the generation and effector function of cytotoxic T lymphocytes. Immunopharmacology (1984) 0.77
Effect of flavonoids on basophil histamine release and other secretory systems. Prog Clin Biol Res (1986) 0.77
Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow. Clin Pharmacol Ther (1985) 0.77
The treatment of asthma--beyond bronchodilators. N Engl Reg Allergy Proc (1985) 0.77
Plasma prostaglandin concentrations in allergic bronchial asthma. Int Arch Allergy Appl Immunol (1978) 0.77
Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med (1996) 0.76
Airway smooth muscle, asthma, and calcium ions. J Allergy Clin Immunol (1984) 0.76
Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol (1987) 0.76
Prolonged oestrogenic and mitogenic activity of tamoxifen in the ovariectomized mouse. J Endocrinol (1978) 0.76
The flavonoids: a brief review and study of effects on antigen-induced histamine release from human basophils. Trans Am Clin Climatol Assoc (1981) 0.76
Electrolyte and fluid appetite and balance in male guinea-pigs: effects of stilboestrol treatment and renal function tests. J Endocrinol (1974) 0.76
Quercetin inhibits anaphylactic contraction of guinea pig ileum smooth muscle. Int Arch Allergy Appl Immunol (1983) 0.76
Efficacy and safety of cetirizine therapy in perennial allergic rhinitis. Ann Allergy (1992) 0.75
Asthma, inhaled allergens, and washing the cat. Am Rev Respir Dis (1991) 0.75
Calcium ions, airway function, and asthma. Asian Pac J Allergy Immunol (1983) 0.75
Administration of ketamine or Innovar by the microdrip technic: a double blind study. Anesth Analg (1977) 0.75
Effects of glucocorticosteroids on the urinary excretion of cyclic AMP and electrolytes by asthmatic children. J Allergy Clin Immunol (1974) 0.75
[Smooth muscle contraction augmenting factor produced by human mononuclear cell. II. Produce by subsets of mononuclear cells and effect on the smooth muscle of the trachea]. Arerugi (1983) 0.75
A rational approach to asthma therapy. Postgrad Med (1980) 0.75
Preparation of rodent kidney for light microscopy by freeze-drying and embedding in water-soluble methacrylate. J R Microsc Soc (1967) 0.75
The molecular configuration of inulin: implications for ultrafiltration theory and glomerular permeability. J Membr Biol (1977) 0.75
Prednisolone disposition in steroid-dependent asthmatics. J Allergy Clin Immunol (1980) 0.75
A statement on the question of allergy to fluoride as used in the fluoridation of community water supplies. J Allergy (1971) 0.75
[Smooth muscle contraction augmenting factor produced by human mononuclear cell]. Arerugi (1983) 0.75
Positive lupus erythematosus preparations and penicillin sensitivity. J Allergy Clin Immunol (1971) 0.75
A study of three untoward reactions to dextran. J Allergy (1970) 0.75
Clinical and biochemical correlations in asthma. Proc Inst Med Chic (1973) 0.75
Prostaglandin E and mitogenic stimulation of human lymphocytes in serum-free medium. Prostaglandins (1978) 0.75
Increased adenosine triphosphatase activity in platelets of asthmatic children. Int Arch Allergy Appl Immunol (1975) 0.75
Passage of inulin and p-aminohippuric acid through artificial membranes: implications for measurement of renal function. J Membr Biol (1975) 0.75
Asthma: the promise of drug therapy. Med Times (1975) 0.75
Asthma and the use of CNS depressants: gender differences. J Asthma (1992) 0.75
An impregnating chamber and polymerization oven for preparing blocks of frozen-dried tissue embedded in methacrylate. Lab Pract (1967) 0.75
The biochemical basis for the modulation of allergic reactions by drugs. Pediatr Clin North Am (1975) 0.75